PROFESSIONAL

ACTLung  

Target Cancer Genomic Profiling Service

 

ACTLung: First Testing For Lung Cancer Patient

Providing tailored drug options through precise genomic profiling for important druggable genes

A Precise Choice for Cancer Genomic Profiling

ACTLungis a next-generation sequencing based assay, sequencing 13 druggable genes and  fusion genes transcripts simultaneously from cancer specimens in our CAP accredited lab. This assay is specially designed for patients with lung cancer, providing tailored genomic profile and recommendations of targeted drugs approved by U.S. FDA.

Exploring Various Genetic Alterations for More Precise Therapeutic Implications

ACTLung performs various genetic variation analysis. Besides single nucleotide variation (SNV) and small insertion/ deletion (InDel), it provides fusion gene detection for more precise implications.



ACTLung

Hallmark of ACTLung

  1. For Solid Tumors

    Select suitable treatment for newly diagnosed patients based on druggable genetic mutations
  2. Precise Report Content

    Targeted therapy and hormonal therapy approved by U.S. FDA or in clinical trials



Why ACTLung

Can be performed Fast and Accurately

  1. Drug Targeted-Based Panel

    Sequencing 13 druggable genes and  fusion genes  with genetic alterations
  2. Offering Tailored Drug Options

    Analyzing single nucleotide variation (SNV), small insertion/deletion (InDel) and fusion gene to provide tailored drug options
  3. Short Turnaround Time

    Providing professional solutions within 8 workingdays. (starting from the day qualified specimen is received at lab)
  4. High Sensitivity

    Using NGS platform for microscale specimens
  5. Pioneering Bioinformatics

    Specializing in cancer biology, medical biology, molecular biology, cell biology, immunology, bioinformatics, data science,and pharmaceutical biology to provide insightful interpretation

Specification


Next Generation Sequencing-ACTLung

13druggable  genes ( TAT : 8 working days)

Image title

Sample Types

FFPE

.5-20 unstained sections (5µm/slide)

.1H&E stained slide (5µm)


Sequencing Mean Depth

≧800 X